Xiao-Yang Ji
Xiao-Yang Ji has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Appolinaire Djikeng
International Livestock Research Institute (ILRI) and Biosciences eastern and central Africa (BecA) Hub, PO Box 30709, Nairobi, Kenya
1 shared publication - Bin Liu
Nei Mongol BioNew Technology Co. Ltd, Hohhot 010020, China
1 shared publication - Gang Niu
Phil Rivers Technology, Beijing, China
1 shared publication - Getinet Mekuriaw Tarekegn
School of Veterinary Medicine and Biosciences (SVMB), Scotland’s Rural College (SRUC), Edinburgh, UK
1 shared publication - Josephine Birungi
Biosciences Eastern and Central Africa (BecA) Hub - International Livestock Research Institute, PO Box 30709, Nairobi 00100, Kenya
1 shared publication - Kassahun Tesfaye
Institute of Biotechnology, Addis Ababa University, Addis Ababa 1000, Ethiopia
1 shared publication
Latest Publications
- Open Access
A literature mining method to judge whether there are uncertainties in empirical-dependent antineoplastic drug distribution in specific clinical scenarios
Cancer clinical practice guidelines recommend different treatment options for different cancer types and are mainly developed by clinicians. In theory, those recommendation schemes that are supported by scientific research should provide better efficacy for patients. However, in actual clinical practice: “Is the choice of a specific antineoplastic drug for a specific cancer supported by the results of molecular biology mechanisms or based on the subjective experience of the clinician?” Answering this question is of significant importance for guiding clinical practice, but there is currently no operational method to provide objective judgment in specific cases. This paper describes a literature mining method that collates information from specific antineoplastic drug-related literature to establish an antineoplastic drug-gene association matrix for global or specific cancer scenarios, and further establishes a standard model and scenario models. Based on the parameters of these models, we constructed a linear regression analysis method to evaluate whether the models in different scenarios deviated from a random distribution. Finally, we determined the possible efficacy of an antineoplastic drug in different cancer types, which was validated by the Genomics of Drug Sensitivity in Cancer (GDSC) database. Using our mining method, we tested 18 antineoplastic drugs in 16 cancer types. We found that cisplatin used in ovarian cancer was more efficacious and may benefit patients more than when used in breast cancer, which provides a new paradigm for rational knowledge-driven drug distribution patterns in clinical practice.
Open AccessA literature mining method to judge whether there are uncertainties in empirical-dependent antineoplastic drug distribution in specific clinical scenarios
Cancer clinical practice guidelines recommend different treatment options for different cancer types and are mainly developed by clinicians. In theory, those recommendation schemes that are supported by scientific research should provide better efficacy for patients. However, in actual clinical practice: “Is the choice of a specific antineoplastic drug for a specific cancer supported by the results of molecular biology mechanisms or based on the subjective experience of the clinician?” Answering this question is of significant importance for guiding clinical practice, but there is currently no operational method to provide objective judgment in specific cases. This paper describes a literature mining method that collates information from specific antineoplastic drug-related literature to establish an antineoplastic drug-gene association matrix for global or specific cancer scenarios, and further establishes a standard model and scenario models. Based on the parameters of these models, we constructed a linear regression analysis method to evaluate whether the models in different scenarios deviated from a random distribution. Finally, we determined the possible efficacy of an antineoplastic drug in different cancer types, which was validated by the Genomics of Drug Sensitivity in Cancer (GDSC) database. Using our mining method, we tested 18 antineoplastic drugs in 16 cancer types. We found that cisplatin used in ovarian cancer was more efficacious and may benefit patients more than when used in breast cancer, which provides a new paradigm for rational knowledge-driven drug distribution patterns in clinical practice.
- Open Access
- 1 September 2018
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 31 (9) , 1393-1400
Variations in mitochondrial cytochrome b region among Ethiopian indigenous cattle populations assert Bos taurus maternal origin and historical dynamics
Objective: This study was carried out to assess the haplotype diversity and population dynamics in cattle populations of Ethiopia. Methods: We sequenced the complete mitochondrial cytochrome b gene of 76 animals from five indigenous and one Holstein FriesianxBarka cross bred cattle populations. Results: In the sequence analysis, 18 haplotypes were generated from 18 segregating sites and the average haplotype and nucleotide diversities were 0.7540 +/- 0.043 and 0.0010 +/- 0.000, respectively. The population differentiation analysis shows a weak population structure (4.55%) among the populations studied. Majority of the variation (95.45%) is observed by within populations. The overall average pair-wise distance (F-ST) was 0.049539 with the highest (F-ST = 0.1245) and the lowest (F-ST = 0.011) F-ST distances observed between Boran and Abigar, and Sheko and Abigar from the indigenous cattle, respectively. The phylogenetic network analysis revealed that all the haplotypes detected clustered together with the Bos taurus cattle and converged to a haplogroup. No haplotype in Ethiopian cattle was observed clustered with the reference Bos indicus group. The mismatch distribution analysis indicates a single population expansion event among the cattle populations. Conclusion: Overall, high haplotype variability was observed among Ethiopian cattle populations and they share a common ancestor with Bos taurus.
- 1 September 2018
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 31 (9) , 1393-1400
Open AccessVariations in mitochondrial cytochrome b region among Ethiopian indigenous cattle populations assert Bos taurus maternal origin and historical dynamics
Objective: This study was carried out to assess the haplotype diversity and population dynamics in cattle populations of Ethiopia. Methods: We sequenced the complete mitochondrial cytochrome b gene of 76 animals from five indigenous and one Holstein FriesianxBarka cross bred cattle populations. Results: In the sequence analysis, 18 haplotypes were generated from 18 segregating sites and the average haplotype and nucleotide diversities were 0.7540 +/- 0.043 and 0.0010 +/- 0.000, respectively. The population differentiation analysis shows a weak population structure (4.55%) among the populations studied. Majority of the variation (95.45%) is observed by within populations. The overall average pair-wise distance (F-ST) was 0.049539 with the highest (F-ST = 0.1245) and the lowest (F-ST = 0.011) F-ST distances observed between Boran and Abigar, and Sheko and Abigar from the indigenous cattle, respectively. The phylogenetic network analysis revealed that all the haplotypes detected clustered together with the Bos taurus cattle and converged to a haplogroup. No haplotype in Ethiopian cattle was observed clustered with the reference Bos indicus group. The mismatch distribution analysis indicates a single population expansion event among the cattle populations. Conclusion: Overall, high haplotype variability was observed among Ethiopian cattle populations and they share a common ancestor with Bos taurus.